retatrutide and type 1 diabetes clinical trial data trials The Effect of Retatrutide on Kidney Parameters in Participants With 2 Mellitus and/or Obesity retatrutide clinical trials safety data – retatrutide mechanism clinical data The

[28] [29] Before starting GLP-1 therapy, your healthcare provider will: Review your complete medical history, including thyroid disease status Ensure thyroid function is optimised Assess for any contraindications Discuss the benefits and risks specific to your situation With appropriate patient selection and monitoring, GLP-1 receptor agonists can be safely prescribed to individuals with Hashimoto's disease when the clinical benefits outweigh potential risks

Protein helps determine whether your smaller meals support muscle, fullness, hair, energy, and recovery

Ongoing efforts are aimed at developing next-generation GLP-1 agonists for obesity and other therapeutic areas

But wait